|Bid||717.50 x 0|
|Ask||718.50 x 0|
|Day's range||717.50 - 734.00|
|52-week range||350.40 - 1,000.00|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||70.39|
|Earnings date||17 Sep 2020|
|Forward dividend & yield||0.08 (1.06%)|
|Ex-dividend date||05 Nov 2020|
|1y target est||1,259.67|
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has launched its Malaysian business with an office in Kuala Lumpur. The new office is part of Clinigen’s strategy to expand its footprint in Southeast Asia, an important market for the Group.
Clinigen Group's (LON:CLIN) stock is up by a considerable 8.0% over the past month. However, we decided to pay...